Combined tDCS and Cognitive Training to Reduce Impulsivity in Patients With Traumatic Brain Injury
1 other identifier
interventional
33
1 country
1
Brief Summary
Behavioral changes following a traumatic brain injury (TBI) are one of the biggest challenges for patients, as well as their family members and others involved in their recovery. One of the most common behavioral changes following TBI is the emergence of impulsive behavior, which has been associated with destructive, suicidal, and aggressive behavior, and is related to poor rehabilitation program adherence. The primary objective of this study is to investigate the effect of a novel neuroplasticity based intervention that combines cognitive training and transcranial direct current stimulation (tDCS) to reduce impulsivity and to improve outcomes and quality of life for those who have suffered a TBI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 8, 2019
CompletedFirst Submitted
Initial submission to the registry
February 13, 2019
CompletedFirst Posted
Study publicly available on registry
February 18, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 16, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedMarch 13, 2024
March 1, 2024
4.2 years
February 13, 2019
March 11, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Barratt Impulsiveness Scale (BIS)
Differences in magnitude of change in BIS scores between active tDCS and sham groups from baseline to follow-up sessions. Higher total score on the BIS indicates higher levels of impulsivity.
Change between baseline and 1 week follow-up; 1, 2, and 3 months following intervention
Secondary Outcomes (2)
Change in choice of higher risk option in the Risk Task
Change between baseline and 1 week follow-up; 1, 2, and 3 months following intervention
Change in Brain Functional Connectivity as measured by functional magnetic resonance imaging (fMRI)
Change between baseline and 1 week follow-up
Study Arms (2)
Active tDCS
EXPERIMENTALParticipants will receive 5 sessions of cognitive training concurrent with transcranial direct current stimulation (anode over left frontal cortex, cathode over right frontal cortex; 2 mAmps for 20 minutes).
Sham tDCS
SHAM COMPARATORParticipants will receive 5 sessions of cognitive training concurrent with sham tDCS. For sham tDCS, electrodes are placed at the same locations as for active tDCS, but current is ramped up for the initial 30 secs, then immediately ramped back down. This method mimics the initial physical sensation of stimulation, but there is no active current for the remainder of the session.
Interventions
Cognitive training concurrent with 2 mAmps of anodal stimulation applied to the left frontal cortex for 20 minutes.
Cognitive training concurrent with sham tDCS (30 secs ramp up/ramp down of current at beginning of session).
Eligibility Criteria
You may qualify if:
- Participants will be included in the study if they:
- have a clinical history of impulsive behavior, including substance abuse, gambling problems, legal issues such as DUI, violent acts, aggression, history of suicidality, or ADHD as assessed by the patient's clinical provider and/or screen of medical records
- are age 18 or older
- are receiving services from the Minneapolis VA Health Care System
- are stable on any medications for at least 1 week at the baseline visit
- have a diagnosis of mild, moderate, or severe TBI (as defined by VA/DoD Clinical Practice Guidelines criteria)
You may not qualify if:
- Persons will be excluded from this study if they:
- have a significant neurological disorder based on the Principal Investigators judgment that would impact risk
- diagnosed with current active psychosis or mania
- have metallic cranial plates/screws or implanted devices
- have eczema on scalp or other scalp lesions or skin disorders that may become irritated by stimulation
- are pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Minneapolis VA Medical Center
Minneapolis, Minnesota, 55417, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Scientist
Study Record Dates
First Submitted
February 13, 2019
First Posted
February 18, 2019
Study Start
January 8, 2019
Primary Completion
March 16, 2023
Study Completion
January 1, 2025
Last Updated
March 13, 2024
Record last verified: 2024-03